Wayne Paes

Company: Grey Wolf Therapeutics

Job title: Senior Scientist

Seminars:

First-In-Class Inhibitors of ERAP1 Generate Novel Targets for MHC-IDirected Therapies 10:20 am

Inhibition of ERAP1 by first-in-class small molecule inhibitors significantly alters the antigenic repertoire of cancer cells Novel ERAP1-independent epitopes are presented on MHC-I molecules for immune recognition Cytotoxic T cell recognition of these novel epitopes mediates tumor cell lysisRead more

day: Day One